IMCD/€IMCD
1D1W1MYTD1Y5YMAX
Capital at risk
About IMCD
IMCD N.V. specializes in the distribution and formulation of chemicals and ingredients. Founded in 1995 and headquartered in Rotterdam, the Netherlands, the company operates in numerous countries across the world, serving a wide range of industries. IMCD provides value-added services such as technical support, formulation, marketing, and logistics, leveraging its extensive network to deliver tailored solutions that enhance product performance and facilitate innovation.
- Ticker
- €IMCD
- Sector
- Industrials
- Primary listing
- AEX
- Employees
- 5,237
- Headquarters
- Rotterdam, Netherlands
- Website
- www.imcdgroup.com
IMCD Metrics
BasicAdvanced
€5.9B
25.43
€3.90
0.96
€1.81
1.83%
Price and volume
Market cap
€5.9B
Beta
0.96
52-week high
€110.00
52-week low
€68.24
Average daily volume
146K
Dividend rate
€1.81
Financial strength
Current ratio
1.347
Quick ratio
0.851
Long term debt to equity
50.571
Total debt to equity
85.125
Dividend payout ratio (TTM)
46.42%
Interest coverage (TTM)
5.56%
Profitability
EBITDA (TTM)
515.928
Gross margin (TTM)
25.01%
Net profit margin (TTM)
4.63%
Operating margin (TTM)
8.07%
Effective tax rate (TTM)
26.49%
Revenue per employee (TTM)
€950,000
Management effectiveness
Return on assets (TTM)
5.24%
Return on equity (TTM)
11.23%
Valuation
Price to earnings (TTM)
25.435
Price to revenue (TTM)
1.178
Price to book
2.77
Price to tangible book (TTM)
-10.88
Price to free cash flow (TTM)
16.165
Free cash flow yield (TTM)
6.19%
Free cash flow per share (TTM)
6.134
Dividend yield (TTM)
1.83%
Forward dividend yield
1.83%
Growth
Revenue change (TTM)
2.69%
Earnings per share change (TTM)
-14.64%
3-year revenue growth (CAGR)
2.68%
10-year revenue growth (CAGR)
11.37%
3-year earnings per share growth (CAGR)
-8.35%
10-year earnings per share growth (CAGR)
11.51%
3-year dividend per share growth (CAGR)
-8.59%
10-year dividend per share growth (CAGR)
15.19%
What the Analysts think about IMCD
Analyst ratings (Buy, Hold, Sell) for IMCD stock.
Analyst projections of the future price of IMCD stock.
Bulls say / Bears say
H1 2026 revenue rose 11% (ccy) to €2 638 million, gross profit increased 7% to €658 million, operating EBITA grew 8% to €285 million, free cash flow jumped 29% to €222 million, and cash EPS improved to €3.18 from €2.94 (Reuters)
IMCD beat Q2 revenue forecasts with sales of $1.37 billion versus a $1.36 billion consensus, driven by an organic growth recovery that spurred a ~7.6% jump in the share price (Investing.com)
UBS upgraded IMCD to “Buy” from “Neutral” and raised its price target to €100, citing a clear path back to 6–7% organic EPS growth for the specialty chemicals distributor (Investing.com)
IMCD’s Q1 2026 EBITA declined 9% year-on-year to €129.8 million, highlighting persistent first-quarter weakness despite a modest beat versus consensus estimates (Investing.com)
More than half of the decline in gross profit margin was attributed to the integration of recently acquired, lower-margin businesses, diluting overall profitability and indicating risks around acquisition execution (Investing.com)
Net debt reached €1 560 million at mid-2026, with a leverage ratio of 2.8 times EBITDA, constraining financial flexibility amid a higher-rate environment and limiting capacity for further bolt-on M&A (European Coatings)
Data summarised monthly by Lightyear AI. Last updated on 25 Aug 2026.
IMCD Financial Performance
Revenues and expenses
IMCD Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing IMCD
AllEURGBPUSD
Fund name | Fund size | €IMCD weighting |
|---|---|---|
iShares STOXX Europe 600 Chemicals€EXV7 | €104M | 2.38% |
iShares EURO STOXX Mid€DJMC | €572M | 0.62% |
iShares EURO STOXX Mid Cap£DJMC | £491M | 0.62% |
iShares AEX€IAEX | €778M | 0.55% |
iShares AEX£IAEX | £668M | 0.55% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.